TY - JOUR
T1 - Serial endoscopy in azoxymethane treated mice using ultra-high resolution optical coherence tomography
AU - Hariri, Lida P.
AU - Qiu, Ziping
AU - Tumlinson, Alexandre R.
AU - Besselsen, David G.
AU - Gerner, Eugene W.
AU - Ignatenko, Natalia
AU - Považay, Boris
AU - Hermann, Boris
AU - Sattmann, Harald
AU - McNally, James
AU - Unterhuber, Angelika
AU - Drexler, Wolfgang
AU - Barton, Jennifer K.
N1 - Funding Information:
Research was partially supported by grants from the National Institutes of Health CA083148, CA095060, CA109385, and the University of Arizona Proposition 301 Imaging Fellowship. Support for the project was also provided by the following institutions: Cardiff University, FWF Y 159-PAT, the Christian Doppler Society, FEMTOLASERS GmbH (Vienna, Austria).
PY - 2007/11
Y1 - 2007/11
N2 - Purpose: Optical coherence tomography (OCT) is a minimally invasive, depth-resolved imaging tool that can be implemented in a small diameter endoscope for imaging mouse models of colorectal cancer (CRC). In this study, we utilized ultrahigh resolution (UHR) OCT to serially image the lower colon of azoxymethane (AOM) treated A/J mouse models of CRC in order to monitor the progression of neoplastic transformations and determine if OCT is capable of identifying early disease. Experimental Design: Thirteen AOM treated A/J and two control A/J mice were surveyed at four timepoints (8, 14, 22 and 26 weeks post AOM treatment) using a 2.0 mm diameter UHR OCT endoscopic system with 3.2 mm axial and 4.4 mm lateral resolution. Histological samples obtained at the final timepoint served as the diagnostic reference. A blinded expert panel of mouse colon pathologists provided diagnoses from the OCT images based on criteria developed from a separate training set of OCT images. Panel results were compared to histological diagnoses assigned by a blinded pathologist. Results: At the final imaging timepoint, 95% of adenomas and 23% of gastrointestinal neoplasias (38% protruding GINs and 9% non-protruding GINs) were correctly diagnosed. The panel identified 68% of disease foci (95% adenoma, 76% protruding GINs and 13% non-protruding GINs). Over the OCT imaging timepoints, disease progression followed a typical succession, with normal or GIN preceding adenoma. Conclusions: Endoscopic UHR OCT enabled accurate diagnosis of adenomas, identification of protruding GIN and non-destructive visualization of CRC progression, providing a tool for cancer research in animal models.
AB - Purpose: Optical coherence tomography (OCT) is a minimally invasive, depth-resolved imaging tool that can be implemented in a small diameter endoscope for imaging mouse models of colorectal cancer (CRC). In this study, we utilized ultrahigh resolution (UHR) OCT to serially image the lower colon of azoxymethane (AOM) treated A/J mouse models of CRC in order to monitor the progression of neoplastic transformations and determine if OCT is capable of identifying early disease. Experimental Design: Thirteen AOM treated A/J and two control A/J mice were surveyed at four timepoints (8, 14, 22 and 26 weeks post AOM treatment) using a 2.0 mm diameter UHR OCT endoscopic system with 3.2 mm axial and 4.4 mm lateral resolution. Histological samples obtained at the final timepoint served as the diagnostic reference. A blinded expert panel of mouse colon pathologists provided diagnoses from the OCT images based on criteria developed from a separate training set of OCT images. Panel results were compared to histological diagnoses assigned by a blinded pathologist. Results: At the final imaging timepoint, 95% of adenomas and 23% of gastrointestinal neoplasias (38% protruding GINs and 9% non-protruding GINs) were correctly diagnosed. The panel identified 68% of disease foci (95% adenoma, 76% protruding GINs and 13% non-protruding GINs). Over the OCT imaging timepoints, disease progression followed a typical succession, with normal or GIN preceding adenoma. Conclusions: Endoscopic UHR OCT enabled accurate diagnosis of adenomas, identification of protruding GIN and non-destructive visualization of CRC progression, providing a tool for cancer research in animal models.
KW - Animal models for carcinogenesis
KW - Azoxymethane treated mouse model of colorectal neoplasm
KW - Colorectal adenoma
KW - Endoscopic imaging
KW - Gastrointestinal cancer
KW - Gastrointestinal intraepithelial neoplasia
KW - Imaging of tumor progression
UR - http://www.scopus.com/inward/record.url?scp=42149084927&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=42149084927&partnerID=8YFLogxK
U2 - 10.4161/cbt.6.11.4852
DO - 10.4161/cbt.6.11.4852
M3 - Article
C2 - 17986850
AN - SCOPUS:42149084927
SN - 1538-4047
VL - 6
SP - 1753
EP - 1762
JO - Cancer Biology and Therapy
JF - Cancer Biology and Therapy
IS - 11
ER -